調查批次:CHT2014-02 | 檢體寄出日期:2014-02-24 | 報告回收截止日期:2014-03-03 | 回收份數:21 |
FT4 檢驗院際品管調查結果: | ||
2.歷次品管檢體 FT4 檢驗值之實驗室間 CV 分佈圖 | ||
4.至本次各單位 z score 分佈圖 | 5.至本次各單位 D% 分佈圖 | 6.至本次各單位 SDI 分佈圖 |
檢驗單位 <代碼> |
確診醫院 <代碼> |
回報 天數 |
檢體 S1 |
檢體 S2 |
||||||||||||
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
|||||
RH01b | RH01 | 2 |
2 |
5 |
1.59 |
-0.28 |
-15.0 |
-1.9 |
-0.6 |
-62 |
3.14 |
-0.68 |
-17.8 |
-2.2 |
-0.7 |
-73 |
RH07b | RH07 | 2 |
2 |
3 |
2.15 |
0.28 |
15.0 |
1.9 |
0.6 |
62 |
4.82 |
1.00 |
26.2 |
3.2 |
0.8 |
108 |
RH14 | RH14 | 3 |
2 |
3 |
2.37 |
0.50 |
26.7 |
3.3 |
1.1 |
111 |
4.74 |
0.92 |
24.1 |
3.0 |
0.7 |
99 |
RH15 | RH15 | 3 |
2 |
5 |
1.28 |
-0.59 |
-31.6 |
-3.9 |
-1.3 |
-131 |
2.21 |
-1.61 |
-42.1 |
-5.2 |
-1.5 |
-173 |
CL009 | CL009 | 2 |
2 |
5 |
1.54 |
-0.33 |
-17.6 |
-2.2 |
-0.8 |
-73 |
2.88 |
-0.94 |
-24.6 |
-3.0 |
-0.9 |
-101 |
CL010 | CL010 | 1 |
2 |
6 |
2.20 |
0.33 |
17.6 |
2.2 |
0.7 |
73 |
5.12 |
1.30 |
34.0 |
4.2 |
1.0 |
140 |
CL012 | CL012 | 4 |
2 |
3 |
1.89 |
0.02 |
1.1 |
0.1 |
0.0 |
4 |
4.35 |
0.53 |
13.9 |
1.7 |
0.4 |
57 |
CL013 | CL013 | 3 |
2 |
5 |
1.56 |
-0.31 |
-16.6 |
-2.1 |
-0.7 |
-69 |
3.47 |
-0.35 |
-9.2 |
-1.1 |
-0.4 |
-38 |
CL015 | CL015 | 7 |
2 |
4 |
2.30 |
0.43 |
23.0 |
2.9 |
0.9 |
96 |
4.56 |
0.74 |
19.4 |
2.4 |
0.6 |
80 |
Median of RIA Group |
1.89 |
4.35 |
||||||||||||||
Range of RIA Group |
1.28 - 2.37 |
2.21 - 5.12 |
||||||||||||||
Robust mean of RIA Group |
1.88 ( n = 9 ) |
3.92 ( n = 9 ) |
||||||||||||||
Robust SD of RIA Group |
0.45 |
1.16 |
||||||||||||||
CV of RIA Group |
23.9% |
29.6% |
||||||||||||||
Median of European RIA Labs |
1.77 ( n = 105 ) |
3.45 ( n = 105 ) |
||||||||||||||
Range of European RIA Labs ( 16% - 84% ) |
1.60 - 2.11 |
2.94 - 3.79 |
||||||||||||||
檢驗單位 <代碼> |
確診醫院 <代碼> |
回報 天數 |
檢體 S1 |
檢體 S2 |
||||||||||||
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
|||||
RH01a | RH01 | 1 |
4 |
9 |
2.20 |
0.33 |
17.6 |
2.2 |
1.6 |
73 |
4.00 |
0.18 |
4.7 |
0.6 |
0.7 |
19 |
RH02c | RH02 | 1 |
4 |
1 |
1.62 |
-0.25 |
-13.4 |
-1.7 |
-0.8 |
-56 |
2.92 |
-0.90 |
-23.6 |
-2.9 |
-1.5 |
-97 |
RH06 | RH06 | 1 |
4 |
9 |
2.14 |
0.27 |
14.4 |
1.8 |
1.3 |
60 |
4.00 |
0.18 |
4.7 |
0.6 |
0.7 |
19 |
RH07a | RH07 | 1 |
4 |
2 |
1.68 |
-0.19 |
-10.2 |
-1.3 |
-0.6 |
-42 |
3.65 |
-0.17 |
-4.5 |
-0.5 |
0.0 |
-18 |
RH12 | RH12 | 2 |
4 |
2 |
1.84 |
-0.03 |
-1.6 |
-0.2 |
0.1 |
-7 |
3.78 |
-0.04 |
-1.0 |
-0.1 |
0.3 |
-4 |
RH19 | RH19 | 2 |
4 |
2 |
1.53 |
-0.34 |
-18.2 |
-2.3 |
-1.2 |
-76 |
3.66 |
-0.16 |
-4.2 |
-0.5 |
0.0 |
-17 |
RH20 | RH20 | 3 |
4 |
7 |
1.69 |
-0.18 |
-9.6 |
-1.2 |
-0.5 |
-40 |
3.24 |
-0.58 |
-15.2 |
-1.9 |
-0.8 |
-62 |
CL005 | CL005 | 1 |
4 |
9 |
2.02 |
0.15 |
8.0 |
1.0 |
0.8 |
33 |
4.37 |
0.55 |
14.4 |
1.8 |
1.5 |
59 |
CL006a | CL006 | 1 |
4 |
7 |
1.67 |
-0.20 |
-10.7 |
-1.3 |
-0.6 |
-44 |
3.17 |
-0.65 |
-17.0 |
-2.1 |
-1.0 |
-70 |
CL008 | CL008 | 1 |
4 |
2 |
1.70 |
-0.17 |
-9.1 |
-1.1 |
-0.5 |
-38 |
3.83 |
0.01 |
0.3 |
0.0 |
0.4 |
1 |
CL011 | CL011 | 0 |
4 |
13 |
1.92 |
0.05 |
2.7 |
0.3 |
0.4 |
11 |
3.97 |
0.15 |
3.9 |
0.5 |
0.7 |
16 |
CL014b | CL014 | 2 |
4 |
1 |
1.83 |
-0.04 |
-2.1 |
-0.3 |
0.0 |
-9 |
3.17 |
-0.65 |
-17.0 |
-2.1 |
-1.0 |
-70 |
Median of CLIA Group |
1.77 |
3.72 |
||||||||||||||
Range of CLIA Group |
1.53 - 2.20 |
2.92 - 4.37 |
||||||||||||||
Robust mean of CLIA Group |
1.82 ( n = 12 ) |
3.65 ( n = 12 ) |
||||||||||||||
Robust SD of CLIA Group |
0.24 |
0.49 |
||||||||||||||
CV of CLIA Group |
13.2% |
13.4% |
||||||||||||||
Median of European CLIA Labs |
1.90 ( n = 957 ) |
3.93 ( n = 957 ) |
||||||||||||||
Range of European CLIA Labs ( 16% - 84% ) |
1.60 - 2.05 |
3.19 - 4.32 |
||||||||||||||
Median of All Labs |
1.83 |
3.78 |
||||||||||||||
Range of All Labs |
1.28 - 2.37 |
2.21 - 5.12 |
||||||||||||||
Robust mean of All Labs |
1.85 ( n = 21 ) |
3.77 ( n = 21 ) |
||||||||||||||
Robust SD of All Labs |
0.33 |
0.77 |
||||||||||||||
CV of All Labs |
17.8% |
20.4%
|
||||||||||||||
Median of All European Labs ( Xa ) |
1.87 |
3.82 |
||||||||||||||
Range of All European Labs ( 16% - 84% ) |
1.60 - 2.06 |
3.15 - 4.31 |
||||||||||||||
Mean of All European Labs |
1.85 ( n = 1146 ) |
3.77 ( n = 1146 ) |
||||||||||||||
SD of All European Labs |
0.23 |
0.59 |
||||||||||||||
CV of All European Labs |
12.4% |
15.5% |
||||||||||||||
SD for proficiency
assessment ( σp ) |
0.15 |
0.31 |
||||||||||||||
|
Method Code
|
Laboratory |
|
Radioimmunoassay ( Competitive-type ) |
2 |
RH01b, RH07b, RH14, RH15, CL009, CL010, CL012, CL013, CL015, |
Chemiluminescent Immunoassay ( Competitive-type ) |
4 |
RH01a, RH02c, RH06, RH07a, RH12, RH19, RH20, CL005, CL006a, CL008, CL011, CL014b, |
Reagent Code |
Laboratory |
|
Abbott Architect |
1 |
RH02c, CL014b, |
Beckman Coulter Access |
2 |
RH07a, RH12, RH19, CL008, |
Cisbio RIA-gnost |
3 |
RH07b, RH14, CL012, |
Diasorin |
4 |
CL015, |
Immunotech |
5 |
RH01b, RH15, CL009, CL013, |
MP |
6 |
CL010, |
Siemens ADVIA Centaur |
7 |
RH20, CL006a, |
Siemens Immulite 2000 |
9 |
RH01a, RH06, CL005, |
Roche |
13 |
CL011, |
若有任何疑問,歡迎來電(函)聯繫或指教
財團法人預防醫學基金會
地 址:10699 台北郵政 26-624 號信箱 電 話:(02)
2703-6080
e-mail:
傳 真: (02)
2703-6070
updated
: 2014-03-27